Is It Time for Cardiologists to Treat Obesity? Is It Time for Cardiologists to Treat Obesity?

Cardiologists Michelle O ' Donoghue and Nicholas Marston discuss the"game changer" trial at AHA showing that GLP-1 agonist semaglutide reduced CV events in patients with ASCVD and overweight/obesity.theheart.org on Medscape
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Commentary Source Type: news